Hyperkalemia - A Pipeline Analysis Report
Published: May 2018 | Pages: 48 | SKU: IRTNTR22837 |
Overview of the drug development pipeline for hyperkalemia
Hyperkalemia is a medical condition in which the level of potassium in the blood stream increases and is categorized into mild hyperkalemia, moderate hyperkalemia, and severe hyperkalemia. Severe hyperkalemia can result in cardiac attest and lead to death. Palpitations, numbness, muscle pain, muscle weakness, nausea are some of the symptoms in patients suffering from severe hyperkalemia. Factors such as dehydration, chronic kidney disease (CKD), and type 1 diabetes are some of the main causes of hyperkalemia. Technavio’s market research analysts have predicted that with the introduction of diuretics, alkalinizing agents, and dialysis as some of the most promising approaches to treat hyperkalemia, the global hyperkalemia market will witness growth in the forthcoming years.
According to this pipeline analysis report, most of the drug development molecules in the pipeline are under the pre-clinical drug development stage. The pipeline landscape in the pipeline analysis report mentions the percentage of drug development molecules that are under phase III stage.
Companies covered
This pipeline analysis report provides a detailed analysis of the companies that are involved in the development of drug molecules for the treatment of hyperkalemia. In addition to providing information on the various stages of molecules developed by companies for different indications, this pipeline analysis report also provides information about the drug development molecules discontinued by companies.
Some of the companies covered in this pipeline analysis report are –
- Ardelyx
- AstraZeneca
- CytoSorbents
Therapeutic assessment of the drug development pipeline for hyperkalemia by indication coverage
- Hyperkalemia
- Severe hyperkalemia
The hyperkalemia therapeutic assessment involves the development of majority of drugs for hyperkalemia in comparison to severe therapeutic assessment. Hyperkalemia can be controlled by medications.
Therapeutic assessment of the drug development pipeline for hyperkalemia by mechanism of action
- Potassium secretagogue
- Potassium binder
According to this pipeline analysis report, some of the molecules that are currently in the drug development pipeline for hyperkalemia are being developed for the potassium binder mechanism of action. Potassium binder are administered orally or by retention enema for hyperkalemia.
Key questions answered in the report include
- What are the drug development molecules in the various development stages for hyperkalemia?
- What are the companies that are currently involved in the development of drug development molecules for hyperkalemia?
- Insight into discontinued/inactive molecules with appropriate reasoning?
- What are the major regulatory authorities approving drugs in various regions?
- Detailed profiling of each active molecule
Technavio also offers customization on reports based on specific client requirement.
PART 01: EXECUTIVE SUMMARY
PART 02: SCOPE OF THE REPORT
PART 03: RESEARCH METHODOLOGY
PART 04: INTRODUCTION
PART 05: MAJOR REGULATORY AUTHORITIES
- US
- Europe
- China
PART 06: PIPELINE LANDSCAPE
PART 07: COMPARATIVE ANALYSIS
- Discovery stage molecules
- Pre-clinical stage molecules
- Inactive and discontinued molecules
PART 08: INDICATION ANALYSIS
PART 09: THERAPEUTIC ASSESSMENT (THERAPY BASED)
PART 10: THERAPEUTIC ASSESSMENT (ROA BASED)
PART 11: THERAPEUTIC ASSESSMENT BY TARGET
PART 12: KEY COMPANIES
- Active companies: Category and parameters
PART 13: APPENDIX
- List of abbreviations
Research Framework
Technavio presents a detailed picture of the market by way of study, synthesis, and summation of data from multiple sources. The analysts have presented the various facets of the market with a particular focus on identifying the key industry influencers. The data thus presented is comprehensive, reliable, and the result of extensive research, both primary and secondary.
INFORMATION SOURCES
Primary sources
- Manufacturers and suppliers
- Channel partners
- Industry experts
- Strategic decision makers
Secondary sources
- Industry journals and periodicals
- Government data
- Financial reports of key industry players
- Historical data
- Press releases
DATA ANALYSIS
Data Synthesis
- Collation of data
- Estimation of key figures
- Analysis of derived insights
Data Validation
- Triangulation with data models
- Reference against proprietary databases
- Corroboration with industry experts
REPORT WRITING
Qualitative
- Market drivers
- Market challenges
- Market trends
- Five forces analysis
Quantitative
- Market size and forecast
- Market segmentation
- Geographical insights
- Competitive landscape
PURCHASE FULL REPORT OF
market
Key Questions Answered
- What are the key global market and the regional market share?
- What are the revenue-generating key market segments?
- What are the key factors driving and challenging this market’s growth?
- Who are the key market vendors and their growth strategies?
- What are the latest trends influencing the growth of this market?
- What are the variables influencing the market growth in the primary regions?
- What are the factors influencing the growth of the parent market?
Why should you prefer Technavio's market insights report?
- Off-the-shelf research reports
- Reports can be tailored to meet the customer's needs
- Trusted by more than 100 fortune 500 organizations
- Information about the market's key drivers, trends, and challenges
- Parent market analysis
- Every week, 50,000 people visit our subscription platform
- Detailed vendors report with competitive landscape
- Covid-19 impact and recovery analysis
- Data on revenue-generating market segments
- Details on the market shares of various regions
- Five-force market analysis